Blood Flow Restriction Therapy in Achilles Injury
Launched by NYU LANGONE HEALTH · Sep 24, 2019
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Blood Flow Restriction (BFR) therapy for people with Achilles injuries. BFR therapy involves gently restricting blood flow in the leg while doing light exercises. The goal is to see how this method can help improve strength and speed up recovery for people dealing with Achilles tendon problems. The study is currently looking for participants who are between 18 and 65 years old, have been diagnosed with an Achilles injury, and plan to receive physical therapy as part of their treatment.
If you join the trial, you can expect to engage in BFR therapy along with your regular physical therapy. It's important to note that the study is not open to everyone; for example, people with certain health issues like poor circulation or those who are either too young or too old are not eligible. This trial is designed to help improve treatment options for Achilles injuries, so if you fit the criteria and are interested, your participation could contribute to valuable research in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with Achilles Injury
- • Must be at least 18 years of age and younger than 65 years of age
- • Intention to receive physical therapy as standard of care
- Exclusion Criteria:
- • Patients with intention to receive standard therapy and not the study therapy
- • Patients with impaired circulation, peripheral vascular compromise, previous revascularization of the extremity, or severe hypertension
- • Younger than 18 years of age or older than 65
- • Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
- • Any patient considered a vulnerable subject
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Guillem Gonzalez-Lomas, MD
Principal Investigator
New York Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials